Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In vitro toxic action potential of anti tuberculosis drugs and their combinations.

Environmental toxicology and pharmacology - 1 Sept 2013

Fatima Riffat, Ashraf Muhammad, Ejaz Sohail, Rasheed Muhammad Adil, Altaf Imran, Afzal Misbah, Batool Zainab, Saleem Umber, Anwar Khaleeq

Abstract excerpt

Tuberculosis (TB) is one of the leading infectious causes of death due to single infectious agent after HIV/AIDS. Rifampicin (RIF), Isoniazid (INH), Ethambutol (EMB), Pyrazinamide (PZA) and/or their combinations are extensively prescribed to treat TB. Despite several therapeutic implications, these drugs also produce several toxic effects at cellular level. MTT assay and Ames test were adopted in this study for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antitubercular Agents
Share to Cricetinae

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Interactions

Share to Drug Therapy, Combination

Share to Inhibitory Concentration 50

Share to Mutagenicity Tests

Share to Salmonella

Share to Toxicity Tests

Source

Identifiers

PMID: 23806997
DOI: 10.1016/j.etap.2013.05.008

Genes

EMB

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In vitro toxic action potential of anti tuberculosis drugs and their combinations.PMID 23806997Read ↗

Deciphering the emerging role of phytocompounds: Implications in the management of drug-resistant tuberculosis and ATDs-induced hepatic damage.Semantic proximity Read ↗

The past, present and future of tuberculosis treatment.Semantic proximity Read ↗

Hepatotoxicity Related to Anti-tuberculosis Drugs: Mechanisms and ManagementSemantic proximity Read ↗

Antimutagenic and anticancer activity of Darjeeling tea in multiple test systems.Semantic proximity Read ↗

In vitro antimycobacterial activity of 2-(((2-hydroxyphenyl)amino)methylene)-5,5-dimethylcyclohexane-1,3-dione: a new chemical entity against Mycobacterium tuberculosis.Semantic proximity Read ↗

Pre-clinical evaluation of quinoxaline-derived chalcones in tuberculosis.Semantic proximity Read ↗

Activity of rifampicin and linezolid combination in Mycobacterium tuberculosis.Semantic proximity Read ↗

In vitro interaction of eupomatenoid-5 from Piper solmsianum C. DC. var. solmsianum and anti-tuberculosis drugs.Semantic proximity Read ↗

Targeting DNA Replication and Repair for the Development of Novel Therapeutics against TuberculosisSemantic proximity Read ↗

A novel C-4-modified isotetrone acts as a potent bio-enhancer to augment the activities of anti-tuberculosis drugs against Mycobacterium tuberculosis.Semantic proximity Read ↗

Evaluation of cytotoxic, antiviral effect and mutagenic potential of a micronutrient combination in vitro cell cultureSemantic proximity Read ↗

Vitamin C inhibits apoptosis in THP‑1 cells in response to incubation with Mycobacterium tuberculosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.